KELLY JOHN ALEXANDER (Interim CFO) sold 1.7% of their position (1.30K shares) of PRECISION BIOSCIENCES INC on the open market
Open‑market sale worth $8.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/4/2025ACC: 0001628280-25-048858
Officer· Interim CFO
Since Jan 2021
-1.30K
Net shares
Net seller
$8.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.60K acquired · 4.91K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.60K
Price / share
—
Trade value
—
% of position
4.8%
11/2/2025
75K→78.60K
Common Stock
Direct
Shares
−1.30K
Price / share
$6.49
Trade value
$8.46K
% of position
1.7%
11/3/2025
78.60K→77.30K
Total
Net shares
+2.30K
Net value
-$8.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/2/2025 | M · Option Exercise | +3.60K | — | — | 4.8% | 75K | 78.60K |
| Common Stock Direct | 11/3/2025 | S · Sale | −1.30K | $6.49 | $8.46K | 1.7% | 78.60K | 77.30K |
| Total | +2.30K | -$8.46K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.60K shares
Shares
−3.60K
Strike price
Held after
0.00
Exercisable
—
11/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.60K shares | 11/2/2025 | M · Option Exercise | −3.60K | — | 0.00 |